These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 2369087

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma.
    Reiter W, Stieber P, Reuter C, Nagel D, Cramer C, Pahl H, Fateh-Moghadam A.
    Anticancer Res; 1997; 17(4B):2903-6. PubMed ID: 9329559
    [Abstract] [Full Text] [Related]

  • 23. How can treatment response be measured in breast cancer patients?
    van Dalen A, van der Linde DL, Heering KJ, van Oudalblas AB.
    Anticancer Res; 1993; 13(5C):1901-4. PubMed ID: 8267398
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W, Stieber P, Reuter C, Nagel D, Lau-Werner U, Lamerz R.
    Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Analysis of serum CYFRA 21-1 concentrations in patients with esophageal cancer.
    Brockmann JG, St Nottberg H, Glodny B, Sprakel B, Senninger N.
    Anticancer Res; 2000; 20(6D):4899-904. PubMed ID: 11332443
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck.
    Inal E, Laçin M, Asal K, Ceylan A, Köybaşioğlu A, Ileri F, Uslu SS.
    Kulak Burun Bogaz Ihtis Derg; 2004; 12(1-2):23-30. PubMed ID: 16010093
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Diagnostic value of the assay of carbohydrate antigen 19-9 in patients with primary bronchial cancer].
    Letanche G, Ogier I, Weynants P, Hartmann DJ, Ville G, Cordier JF, Brune J.
    Rev Pneumol Clin; 1985; 41(5):314-6. PubMed ID: 3006207
    [Abstract] [Full Text] [Related]

  • 37. The diagnostic value of the measurement of matrix metalloproteinase 9 (MMP-9), squamous cell cancer antigen (SCC) and carcinoembryonic antigen (CEA) in the sera of esophageal cancer patients.
    Mroczko B, Kozłowski M, Groblewska M, Łukaszewicz M, Nikliński J, Jelski W, Laudański J, Chyczewski L, Szmitkowski M.
    Clin Chim Acta; 2008 Mar; 389(1-2):61-6. PubMed ID: 18155162
    [Abstract] [Full Text] [Related]

  • 38. Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse.
    Nicolini A, Caciagli M, Zampieri F, Ciampalini G, Carpi A, Spisni R, Colizzi C.
    Cancer Detect Prev; 1995 Mar; 19(2):183-95. PubMed ID: 7750106
    [Abstract] [Full Text] [Related]

  • 39. [Clinical significance of CA 15-3 assay as a tumor marker].
    Goto M, Adachi I.
    Nihon Rinsho; 1990 Feb; 48 Suppl():967-70. PubMed ID: 2355637
    [No Abstract] [Full Text] [Related]

  • 40. [Tumor marker: practical usage of tumor marker for recurrent breast cancer--our experience].
    Yoshimoto M.
    Gan To Kagaku Ryoho; 1990 Nov; 17(11):2277-83. PubMed ID: 2241194
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.